Andrx to Present at Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
February 02 2006 - 1:18PM
Business Wire
Andrx Corporation (Nasdaq:ADRX) is scheduled to present on Tuesday,
February 7, 2006, at 3:20 p.m. ET at the Merrill Lynch Global
Pharmaceutical, Biotechnology & Medical Device Conference, at
the Grand Hyatt in New York City. Angelo C. Malahias, Andrx
Corporation's President, will present on behalf of the Company and,
accompanied by Larry Rosenthal, President of Andrx Pharmaceuticals,
Inc., Andrx's generic business, will address questions from the
audience. The presentation and question and answer session will be
webcast live on the Internet at the following web address:
http://www.wsw.com/webcast/ml53/adrx/. A replay of the presentation
will be available approximately three hours after the broadcast and
will be available until February 21, 2006. It may be accessed
through the same web address. A link to the broadcast, along with
the slides for this presentation, will be available on Andrx's
website at: http://www.andrx.com. About Andrx Corporation We are a
pharmaceutical company that: -- develops, manufactures and
commercializes generic versions of controlled-release, niche and
immediate-release pharmaceutical products, including oral
contraceptives; -- distributes pharmaceutical products, primarily
generics, which have been commercialized by others, as well as our
own, primarily to independent pharmacies, pharmacy chains and
physicians' offices; and -- develops and manufactures
pharmaceutical products for other pharmaceutical companies,
including combination products and controlled-release formulations
utilizing our patented technologies and formulation capabilities.
This release and additional information about Andrx Corporation is
also available on the Internet at: http://www.andrx.com.
Andrx (NASDAQ:ADRX)
Historical Stock Chart
From May 2024 to Jun 2024
Andrx (NASDAQ:ADRX)
Historical Stock Chart
From Jun 2023 to Jun 2024
Real-Time news about Andrx (NASDAQ): 0 recent articles
More Andrx Corporation News Articles